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Despite years of research, understanding of the
space radiation environment and the risk it poses to
long-duration astronauts remains limited. There is
a disparity between research results and observed
empirical effects seen in human astronaut crews,
likely due to the numerous factors that limit terres-
trial simulation of the complex space environment
and extrapolation of human clinical consequences
from varied animal models. Given the intended fu-
ture of human spaceflight, with efforts now to rapidly
expand capabilities for humanmissions to the moon
and Mars, there is a pressing need to improve upon
the understanding of the space radiation risk, pre-
dict likely clinical outcomes of interplanetary radia-
tion exposure, and develop appropriate and effective
mitigation strategies for future missions. To achieve
this goal, the space radiation and aerospace com-
munity must recognize the historical limitations of
radiation research and how such limitations could
be addressed in future research endeavors. We have
sought to highlight the numerous factors that limit
understanding of the risk of space radiation for hu-
man crews and to identify ways in which these limita-
tions could be addressed for improved understand-
ing and appropriate risk posture regarding future hu-
man spaceflight.
Introduction
While space radiation research has expanded rapidly
in recent years, large uncertainties remain in predicting
and extrapolating biological responses to radiation ex-
posure in humans. As future missions explore outside
of low-Earth orbit (LEO) and away from the protection
of the Earth’s magnetic shielding, the nature of the ra-
diation exposures that astronauts encounter will include
higher radiation exposures than any experienced in his-
torical human spaceflight. In 1988, the National Coun-
cil on Radiation Protection and Measurements (NCRP)
released Report No. 98: Guidance On Radiation Re-
ceived in Space Activities.1 In this report, authors rec-
ommended that NASA astronauts be limited to career
lifetime radiation exposures that would induce no more
than a 3% Risk of Exposure-Induced Death (REID).
This was re-emphasized in the 2015 NCRP Commen-
tary No. 23: Radiation Protection for Space Activities:
Supplement to Previous Recommendations, which con-
cluded that NASA should continue to observe the 3%
REID career limit for future missions outside of LEO.2
This limit has been accepted in NASA’s Spaceflight
Human-System Standard document, NASA STD-3001
Volume 1 (Revision A).3
Despite the adoption of these guidelines and the past
30 years of research, there has been little progress on
fully defining or mitigating the space radiation risk to hu-
man crew. In fact, the NCRP’s recent conclusions spec-
ified that their 3% limit may not be conservative enough
given the incomplete biological data used in existing pro-
jection models, and that such models may overestimate
the number of allowable "safe days" in space for mis-
sions outside of LEO.2 As a result, NASA has yet to es-
tablish mission exposure limits for crews of exploration-
class missions outside of LEO.
A recent report by Schwadron et al. has identified
further concerns regarding the interplanetary radiation
environment.4 The unusually low activity between so-
lar cycles 23 and 24 (1996-present) has resulted in the
longest period of minimum solar activity observed in over
80 years of solar measurements. The lack of solar activ-
ity has led to a substantial decrease in solar wind density
and magnetic field strengths that typically attenuate the
fluence (the flux of particles crossing a given plane) of
Galactic Cosmic Ray (GCR) ions during periods of so-
lar minimum. As a result, Schwadron et al. project that
GCR fluences will be substantially higher during the next
solar cycles (24-25) leading to increased background ra-
diation exposure and, subsequently, as much as a 20%
decrease in the allowable safe days in space (outside of
LEO) to stay below the 3% REID limits.4
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FIG. 1: Depth dose, energy, and linear energy transfer char-
acteristics of protons. The range of proton energies relative to
the body diameter (dotted lines) and bone marrow depth (or-
dinate) for mice, pigs, and humans for energies up to 60MeV.
The study of human health risks of spaceflight (e.g.
bone health, behavior, nutrition, etc.) typically involves
analogs that closely represent the space environment.
In most cases, theory, models, and study outcomes can
be validated with available spaceflight data or, at a min-
imum, observation of humans subjected to analog ter-
restrial stresses. In contrast, space radiation research is
limited to the use of analogs or models that for many rea-
sons do not accurately represent the operational space
radiation environment or the complexity of human phys-
iology. For example, studies on the effects of space ra-
diation generally use mono-energetic beams and acute,
single-ion exposures (including protons, lithium, carbon,
oxygen, silicon, iron, etc.) instead of the complex energy
spectra and diverse ionic composition of the space radi-
ation environment. In addition, a projected, cumulative
mission dose is often delivered in one-time, or rapid and
sequential, doses delivered to experimental animals. In
most cases, these dose-rates are several orders of mag-
nitude higher than actual space environment exposures.
Even the use of animal models introduces error, as stud-
ies make use of a variety of animal species with differing
responses and sensitivity to radiation that may not rep-
resent human responses to similar exposures. Further,
studies do not challenge multiple organ systems to re-
spond concurrently to the numerous stressors seen in an
operational spaceflight scenario. Historical epidemiolog-
ical studies of humans, which are generally used for cor-
relation of animal and experimental models, include pop-
ulations such as atomic bomb or nuclear accident sur-
vivors exposed to whole-body irradiation at high doses
and high dose-rates, limited to scenarios not found in
spaceflight. These disparities and numerous other en-
vironmental considerations contribute to the large uncer-
tainties in the outcomes of space radiobiology studies
and the applicability of such studies for extrapolation and
prediction of clinical health outcomes in future space-
flight crews.
Here we seek to highlight these factors that contribute
to the challenge of radiation risk prediction andmitigation
for future exploration spaceflight. Our intent is to provide
an understanding of the current state of radiation-specific
literature, efforts towards better defining the space radia-
tion environment, and the difficulties in realization of this
effort that limit current knowledge. Further, we hope to
identify opportunities for future research that could best
elucidate a path towards successful definition and miti-
gation of the space radiation risk to humans outside of
LEO.
The Space Radiation Environment
Biological stressors related to space radiation are due
to the effects of energy transfer from a charged particle to
the human body. The combination of a particle’s charge,
mass, and energy determines how quickly it loses en-
ergy when interacting with matter.5–7 For example, given
equal initial kinetic energies, an electron will penetrate
further into aluminum than a heavy charged particle, and
an x-ray will, on average, penetrate even further. In bio-
logical tissue, the absorbed dose that a particular target
organ receives from heavy-charged particle radiation de-
pends not only on the energy spectrum of the particles
but also on the depth and density of the tissue mass that
lie between the skin surface and the target organ (for
example, see Figure 1, which demonstrates the tissue
depth ionized hydrogen (proton) penetrates as a function
of energy).
The radiation dose to an astronaut, measured in units
of Gray (Gy, defined as Joules per kilogram (J/kg)), is
deposited with a distribution in tissues that results from
the specific energy fluence of the particles. The heavier
the charged particle, the greater the amount of energy
deposited per unit path length for that particle. This is
called linear energy transfer (LET).
The space weather environment is most commonly
categorized into three sources of ionizing radiation, each
of which is associated with different energy and preva-
lence and, thus, different radiation-related risk (Figure
2). First, the GCR spectrum consists of primarily ion-
ized hydrogen as well as less frequent heavier-charged
particles, with relatively high LET, that contribute to the
chronic, background radiation exposure for long-duration
astronauts. Solar Particle Events (SPEs) consist mostly
of short-duration exposures of high-energy protons that
emanate from the Sun within regions of solar magnetic
instability.8 Finally, solar wind consists of mostly low en-
ergy protons and electrons. The background dose-rate
for solar wind varies with the solar cycle, but is easily
shielded by modern spacecraft designs and is consid-
ered to be of negligible risk. In addition to space envi-
ronment radiation, some small amounts of radioisotopes
are used in manned space missions for instrument cali-
bration and research; however, these sources are highly
3FIG. 2: Interplanetary Radiation Environment. Galactic Cosmic Rays (GCR) and unpredictable Solar Particle Events (SPEs)
pose a significant threat to astronauts during exploration missions to the moon or Mars. Each radiation source has a unique
impact on tissue health, shielding design, and mitigation strategies during spaceflight operations. We are uncertain of how
simultaneous and prolonged exposure to these radiations will affect short- or long-term human health. Illustration by R. Blue.
controlled by flight rules and mission planners. The vast
majority of crew radiation exposures are delivered by the
complex radiation environment in which they must travel
and live.
Galactic Cosmic Rays
GCR ions, originating from outside our solar system,
are relativistic nuclei that possess sufficient energies to
penetrate any shielding technology used on current mis-
sion vehicles.9 The GCR spectrum is a complex com-
bination of fast-moving ions derived from most atomic
species found in the periodic table.10 The GCR spec-
trum, from hydrogen (Z, or atomic number, of 1) through
iron (Z=26), is shown in Figure 3. This spectrum con-
sists of approximately 87% hydrogen ions (protons), 12%
helium ions (α particles), and 1-2% heavier nuclei with
charges ranging from Z=3 (lithium) to Z=28 (nickel).10,11
Ions heavier than nickel are also present, but they are
rare in occurrence. GCR ions with charge Z ≥ 3 are
frequently referred to as HZE particles (High nuclear
charge Z and energy E).
During transit outside of LEO, every cell nucleus within
an astronaut’s body would be traversed by a hydrogen
ion or delta ray (a recoil electron caused by fragmenta-
tion after ion interactions) every few days, and by a heav-
ier GCR ion (e.g. O, Si, Fe) every few months.12,13 De-
spite their infrequency, the heavy ions contribute a signifi-
cant amount to theGCRdose that astronauts would incur
outside of LEO. The energies of the heavier GCR ions
are so penetrating that shielding can only partially re-
duce the intravehicular doses.13 Thicker shielding could
provide protection, but is limited by mass and volume re-
strictions of exploration vehicles and dependent upon the
capabilities of spacecraft launch systems.
The high-LET radiation found in the GCR spectrum
can produce excessive free radicals that instigate ox-
idative damage to cell structures. Chronic exposure to
such oxidative stress contributes to the radiation-induced
changes associated with premature aging, cardiovascu-
lar disease, and the formation of cataracts. The large
ionization power of GCR ions makes them a potentially
significant contributor to tissue damage and carcinogen-
esis, central nervous system (CNS) degeneration, and
deleterious health outcomes.14,15 In addition, as GCR
ions pass through a space vehicle, interaction with the
spacecraft hull attenuates the energy of heavy-charged
particles and frequently causes their fragmentation into
numerous particles of reduced atomic weight, a pro-
cess referred to as spallation.16,17 Spallation occurring
as GCR particles collide with shielding materials can
result in ‘cascade showers’ that produce progeny ions
with much higher potential for biological destruction than
the original particle.9,13,18,19 This process changes the
makeup of the intravehicular radiation spectrum, adding
to the complexity of the radiation environment unique to
spaceflight.
4Solar Particle Events
During SPEs, magnetic disturbances on the surface
of the sun result in the release of intense bursts of ioniz-
ing radiation that are difficult to forecast in advance.20–22
SPE radiation is primarily composed of protons with ki-
netic energies ranging from 10MeV up to several GeV
(determined by the relativistic speed of particles) and is
predicted to produce a heterogeneous dose distribution
within an exposed astronaut’s body, with a relatively high
superficial (skin) dose and a significantly lower dose to
internal organs.
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FIG. 3: Relative abundance of atomic species, normalized to
Z=1 (hydrogen) and up to Z=26 (iron), in the Galactic Cos-
mic Ray (GCR) spectrum. The GCR spectrum includes ev-
ery atom in the periodic table, with ions up to nickel (Z=28)
contributing to any significance. Note the energy of each ion
species varies widely, more prominently in the range of 400-
600MeV. This broad disparity in ions and energies makes it ex-
tremely difficult to accurately simulate the GCR environment
during ground-based radiobiology experiments. While larger
ions may provide lower relative contribution to the spectrum
makeup they may have a more significant biological impact
than smaller, abundant ions. Figure adapted from Simpson
et al. 1983.10
As extravehicular space suits provide relatively low
shielding protection, SPE exposures occurring during
extravehicular activities would pose significant risk to
astronauts.23 However, astronauts would still receive
potentially significant elevations in radiation dose even
within a shielded spacecraft and remain vulnerable, es-
pecially on long-duration missions, to both acute effects
of sudden SPE radiation boluses and to the overall addi-
tive effects of GCR and repetitive SPEs over the course
of a mission.
While many SPEs show modest energy distributions,
there are occasional and unpredictable high fluence
events; for example, a particularly large SPE in Octo-
ber 1989 is predicted to have delivered dose-rates as
high as 1,454mGy/hour to an exposed astronaut in a ve-
hicle traveling in interplanetary space (for context, con-
sider that the daily dose for long-duration astronauts
aboard the ISS is approximately 0.282mGy per day).23–25
Similarly, some SPE can deliver particularly high-energy
doses: for example, 10-15% of the total fluence of an Oc-
tober 1989 SPE was made up of protons with energies
in excess of 100MeV.1,23 If an astronaut were exposed to
such an event during long-duration spaceflight, there are
potential risks for both acute radiation-induced illnesses
and for significant increase in the overall mission dose
accumulation. It should be noted that these predictions
made use of classic shielding values (5g/cm2) similar to
those of the Apollo command module (average shielding
of 6.15g/cm2).26
Energetic SPE events produce protons with ener-
gies ≥ 100MeV that would penetrate classic space-
craft shielding, potentially reaching blood-forming organ
depths with deleterious clinical sequelae. These highly
energetic SPE exposures delivered to crews undertak-
ing interplanetary flight could result in potentially seri-
ous symptoms ranging from prodromal responses (nau-
sea, vomiting, fatigue, weakness) to fatality. In addition,
large SPE doses can produce degenerative effects as-
sociated with cancer, ocular cataracts, respiratory and
digestive diseases, and damage to the microvascula-
ture; while these effects are mostly latent and do not
necessarily pose an immediate risk to crew health, their
overall impact upon long-duration crews is an important
consideration.27
Interplanetary Radiation Environment
The fluence of GCR particles in interplanetary space
fluctuates inversely with the solar cycle, with dose-
rates of 50-100mGy/year at solar maximum to 150-
300mGy/year at solar minimum.28 The fluence and oc-
currence of SPEs is unpredictable, but dose-rates as
high as 1,400–2,837mGy/hour are possible.1,8,23
As discussed above, even if shielding in spacecraft ef-
fectively reduces radiation dose to the crew from SPEs,
spallation occurring as GCR particles collide with shield-
ing materials may lead to biological damage.9,13,18,19 Alu-
minum shielding greater than 20-30g/cm2 could only re-
duce the GCR effective dose by no more than 25%.30
An equivalent mass of polyethylene would only provide
about a 35% reduction in GCR dose.31,32 While this de-
gree of shielding has been achieved aboard the Interna-
tional Space Station (ISS), similar shielding is impracti-
cal within exploration mission design parameters due to
the limited lift-mass capabilities of planned space launch
systems. The Apollo crew module is the only vehicle to
date that has transported humans outside of LEO; this
vehicle could only effectively shield SPE protons with en-
ergies ≤75MeV.26 To date, no studies have successfully
emulated the complexity of energetic elements of the in-
travehicular radiation spectrum that astronauts are actu-
ally exposed to during space travel, or successfully in-
corporated vehicular design and shielding parameters in
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FIG. 4: (a): The Bragg peak and depth dose characteristics of space radiation. The Bragg peak and relative dose deposition for
ions at energies commonly used in space radiation studies compared to the x-ray and gamma sources used as surrogate radiations
for Relative Biological Effectiveness (RBE) quantification. The Bragg peak refers to the point where a charged particle promptly
loses kinetic energy before coming to rest in a medium. This effect is very pronounced for fast moving, charged particles. Shown
are 60MeV Protons (hydrogen, purple), 600MeV 56Fe (iron, light blue), 290MeV12C (carbon, green), 1GeV 56Fe (iron, dark
blue), x-ray (orange dotted line), and 60Co (cobalt, yellow dotted line). The shaded gray area, representing the average diameter
of a mouse, demonstrates that the Bragg peak, and thus the majority of dose deposition, is outside the mouse body for SPE
protons (energies ≥50MeV) and GCR ions. (b): The proton and electron range, energy and dose distributions for the October
1989 solar particle event compared to a dose-equivalent 60Co exposure. Charged particles (electrons, protons, heavy-charged
particles) typically deposit more energy towards the end of their range. In contrast, the current standard, 60Co radiation, loses
the most energy at the tissue surface. These energy characteristics demonstrate the poor fidelity of 60Co as a surrogate for
studying the complex SPE and GCR spectrums. Adapted from Cengel et al. 201029.
analog testing environments, limiting the understanding
of the true effects of such an environment on the human
body.
Challenges in Estimating Radiobiological Effect
Modeling the Transfer of Energy
As a charged particle traverses a material (such as
spacecraft shielding, biological tissue, etc.), it continu-
ously loses energy in particle interactions until the parti-
cle escapes the medium or has slowed enough to have
strong interactions with orbiting electrons. This results
in a rapid loss of particle energy over a very small dis-
tance with a corresponding rapid and sharp rise in LET.
The ‘Bragg peak’ (Figure 4(a)) describes the rapid trans-
fer of kinetic energy from a charged particle before the
particle comes to rest in a medium. This peak is par-
ticularly pronounced for fast-moving, charged particles,
indicating more substantial energy transfer and, as a re-
sult, the potential for greater deleterious biological effect
from such particles. However, if a particle instead passes
directly through tissue without sufficient energy loss to
provide effective stopping power, the sudden energy loss
associated with a Bragg peak does not occur and dam-
age is minimal. Space radiation studies to date gen-
erally presume a homogeneous distribution of energy
loss inclusive of the Bragg peak for each type of radi-
ation, likely overestimating the relative damage of some
exposures.29 Improved modeling of dose deposition and
resultant biological sequelae specific to the space envi-
ronment would advance risk estimation capabilities.
The biological effects of space radiation depend on
multiple particle- and energy-specific factors, such as the
LET specific to each ion, as well as the dose-rate of ex-
posure. The Relative Biological Effectiveness (RBE) of
a particular radiation type is the numerical expression of
the relative amount of damage that a fixed dose of that
type of radiation will have on biological tissues. Higher
RBEs are associated with more damaging radiation for
a given dose. RBE is determined using the effective-
ness of cobalt (60Co) gamma rays as a standard. An
RBE=1 means that the "test" radiation type (for exam-
ple, heavy ion exposure) is as effective as 60Co radiation
at producing a biological effect, and an RBE>1 means
that the test radiation is more effective than 60Co radia-
tion at producing a biological effect. However, in some
cases this comparative value does not fully represent the
energy transfer curve of a specific radiobiological insult
(Figure 4(b)).
The effect of quantifying factors such as LET, particle
identity, dose-rate, and total dose on RBE remains in-
completely understood. The RBE can vary for the same
particle type, depending on energy, dose-rate, target or-
gan, and other factors. Different particle types are as-
signed a radiation weighting factor (formerly quality fac-
tor),WR, that represents an average of calculated RBEs
for a given particle. To identify the relative biological risk
of a specific type and dose of radiation exposure, the
physical dose (in Gy) is multiplied by WR to obtain the
6biologically effective dose in units of Sieverts (Sv). This
method of estimating dose and relative effect introduces
limitations in predicting the true biological risk of expo-
sures, particularly exposures to complex and poorly un-
derstood radiation environments.
Limitations of Terrestrial Analogs
Mechanisms of Biological Impact
There are numerous limitations of current terrestrial
analogs used for studying and predicting space radi-
ation effects on biological tissues. The mechanisms
that cause biological damage from space radiation are
uniquely different from those associated with terrestrial
radiation sources that are frequently used as surrogates
in space radiobiology studies. Charged particle radia-
tion, including GCR and SPE, causes primarily direct
ionization events, where biological effects are the direct
result of interactions between the charged ion and im-
pacted tissue. As charged particles lose energy suc-
cessively through material interactions, each energy loss
event can result in damage to the biological tissue.
In contrast, terrestrial analogs often use radiation that
causes indirect ionizing events. In indirect ionization,
non-charged particles, such as photons, interact with
other molecules and cause the release of charged par-
ticles, such as free radicals or electrons, that ultimately
cause biological damage. Thus, it is difficult to extract
a meaningful estimation of the direct ionizing space ra-
diation impact through the use of terrestrial analogs and
indirect ionizing radiation.
Cumulative Dose Delivery and Tissue Distribution
Models of the space environment outside of LEO
have predicted that astronaut crews may receive a total
body dose of approximately 1-2mSv/day in interplane-
tary space and approximately 0.5-1mSv/day on the Mar-
tian surface.13,33 These doses would increase with any
SPE encountered over the course of the mission.
Many recent studies have led to ominous conclusions
regarding the non-acute effects of GCR radiation on CNS
and cardiovascular health that are difficult to interpret as
real effects likely to occur in humans, but suggest that
the protracted, low dose and dose-rate radiation expo-
sure expected on the longer, exploration missions might
lead to mission-relevant threats to astronaut health.34,35
These experiments were performed using rodent mod-
els exposed to single ion, mono-energetic heavy-ion
beams, in some cases at total doses that are many times
higher than the radiation human crews would experience
during interplanetary space travel.36–38 Even in studies
where lower total doses are used, study methods de-
livered the cumulative mission doses for an entire mis-
sion over a very short period of time, typically over a few
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FIG. 5: Simulated gamma, proton, electron ranges in tissue.
Displayed are the integrated LET/day values measured by
Badhwar et al. 1998 (purple dotted line)11, as well as the LET
of five single-ion exposures (290MeV 14C (carbon), 600MeV
16O (oxygen), 1GeV 47Ti (titanium), 1GeV 56Fe (iron), and
600MeV 56Fe (iron)). As studies generally focus on a single,
mono-energetic radiation exposure, this figure highlights the
lack in breadth of energies or radiation field complexity used
in current radiobiological studies.
minutes.39,40 These parameters do not allow for critical
physiologic components of the radiobiological response
that would be expected under chronic, low-dose and low-
dose-rate radiation conditions, such as cell regrowth and
up-regulation of repair mechanisms.6 Additionally, there
is substantial evidence that GCR exposure at the dose-
rates expected in interplanetary space may not induce
acute or subacute biological responses, while acute ex-
posure to total/cumulative dosage easily could.27
Recently, NASA has developed an updated GCR sim-
ulator capable of providing three to five consecutive
mono-energetic ion beams, with rapid switching between
ion species.39 The NASA Space Radiation Laboratory
(NSRL) is located at Brookhaven National Laboratory in
Brookhaven, NY. Currently, NSRL is the only U.S. facil-
ity with the capapbilites to generate heavy-charged par-
ticles at energies relevent to space radiation studies.
While an improvement upon previous methods, NASA’s
new GCR simulator remains limited in its ability to emu-
late the GCR environment of deep space. The simula-
tor lacks the capacity to generate the pions (subatomic
particles) and neutrons that would follow spallation re-
actions, though these would make up 15-20% of a true
intravehicular dose.41,42 Sequential beam exposures re-
main ineffective in modeling complex and simultaneous
exposures of the actual GCR environment, and there is
significant debate regarding the appropriate order of ion
exposures delivered (as alteration of exposure sequence
can affect the outcomes of an experiment).42,43 Finally,
dose-rate delivered by this simulator will remain signifi-
cantly higher than the radiation dose-rate anticipated for
human crews during spaceflight.39,41
7As an additional challenge, SPE radiation has a
unique dose distribution with respect to whole body ir-
radiation. Research has demonstrated that the biologi-
cal response to space radiation is unique due to a non-
homogeneous, multi-energetic dose distribution.44,45
The majority of the protons in SPEs have energies less
than 100MeV, with Bragg peaks that occur inside the
body and LET of 10-80keV/µm (Figure 4(b)). At these
energies, an exposed human would be expected to re-
ceive a much higher absorbed dose to skin and subcu-
taneous tissues than to internal organs.23,29,46,47 Until re-
cently, these SPE-specific toxicity profiles and dose dis-
tributions were poorly understood. As a result, the major-
ity of prior research has been based largely on simplified
models of radiation transport, relying upon simple spher-
ical geometry to estimate organ dose approximation at
average depths.48,49 However, with this new evidence of
heterogeneous dose distribution, spherical geometry is
insufficient for the modeling of radiation delivered within
the space environment.
Animal Model Sensitivity and Dose Simulation
For ease of dose specification and modeling, mono-
energetic protons and GCR ions in the 100-1,000MeV
range are often used for in vivo animal model experi-
ments such that the entire target is contained within the
plateau portion of the depth-dose distribution.50–54 In ex-
perimental animals that are much smaller than humans,
simple scaling of particle energies to match dose distri-
bution dramatically alters the LET spectrum for the pro-
tons (Figures 4 and 5). Conversely, delivering a sim-
ulated SPE or GCR exposure to smaller animals with-
out scaling the energies would match their respective
LET spectrum but create an heterogeneous dose dis-
tribution that is higher to internal organs than to super-
ficial tissues, the exact inverse of the human SPE dose
distribution.29 For smaller animals (such as rodents), it is
not possible to match both the LET spectrum and dose
distribution of an SPE using protons.29,55,56 Larger ani-
mal models, such as pigs or primates, allow for match-
ing of the anticipated dose distribution for human SPE
exposure using protons with a similar LET spectrum;
thus, larger animal models are more likely than smaller
species to provide robust estimations of human-specific
space radiation effects.29 However, it remains unclear
whether the concurrent exposure to low-dose and dose-
rate GCR radiation can be successfully emulated in small
or large animal models.57 Modeling of GCR radiation
effects may be similarly altered by variations in animal
species; however, without dedicated efforts towards ex-
panding understanding of these phenomena, prediction
of the biological consequences of long-term GCR expo-
sure will remain theoretical at best.
Animal models pose further challenges in the develop-
ment of meaningful and accurate analog research. While
animal models are used in radiobiology studies as surro-
TABLE I: LD50 of various animal models used in space radio-
biology studies compared to the human LD50 dose following
radiation exposures. This broad spectrum in LD50 values em-
phasizes the difficulty in interpreting results of studies using
specific radiation exposures in different animal models and
translating them into clinical outcomes in humans. Note: Ta-
ble is adapted from the reported results of Harding 1988,63
Morris & Jones 1988,64 and Hall & Glaccia 2012.6
Species LD50,(Gy) Reference
Ferret < 2 Harding
Pigs 2.57 Morris & Jones
Dogs 2.62 Morris & Jones
Primates 4.61 Morris & Jones
Mice 8.16 Morris & Jones
Humans 3–4 Hall & Garcia
gates to obtain data that typically cannot be gained in eth-
ical studies of humans, there are numerous metabolic,
anatomic, and cellular differences between humans and
other animal species.58 Most of the animals used in all
U.S. scientific research are mice and rats, bred specifi-
cally for use in research endeavors. While larger species
are likely to provide more meaningful correlation to hu-
man effects,59 due to animal protection issues and rela-
tive societal value, less than one quarter of 1% of scien-
tific studies are performed on non-human primates and
less than one half of 1% of studies use dogs and cats.
Few studies utilize rabbits, guinea pigs, sheep, pigs, or
other large mammals. While rodent experiments have
contributed significantly to our understanding of mech-
anisms of disease, including disease caused by radia-
tion, their value in predicting the effectiveness of treat-
ment modalities for human application has remained
controversial.60–62
Differences between animals and humans are clearly
demonstrated by the characteristics of radiation-induced
death (RID). The LD50 defines the required dose of an
agent (e.g. radiation) necessary to cause fatality in 50%
of those exposed. As illustrated in Table I, remarkably
different LD50 values have been reported for radiation ex-
posure among different species. Currently, the genetic
and physiologic basis for inter- and intra-species vari-
ation in LD50 is not well understood. Mice have been
the most extensively developed model for human dis-
eases including radiation-induced tissue damage. Ro-
dent models have a high potential utility in describing the
physiologic and genetic basis for many aspects of the
mammalian radiation response. Even so, it should be
noted that, in addition to simple physiological differences
between mice and larger animals (including significantly
higher metabolic rate, shorter lifespan, and lower body
mass), the LD50 for mice is significantly higher than that
of most other mammalian species, including humans.
It has been proposed that the differences between the
LD50 values for humans compared to small mammals,
like rodents, are due to different mechanisms involved in
RID at these dose levels. For mammals, death at the
8LD50 dose is thought to be caused by the hematopoi-
etic syndrome, which includes destruction of precursor
cell lines within blood-forming organs. Historically, it
was thought that infection and hemorrhage are the ma-
jor causes of death from hematopoietic syndrome, with
one or the other of these factors predominating in dif-
ferent species’ responses to lethal radiation exposure.65
For example, bacterial infection is the predominate fac-
tor leading to RID in mice at doses near their respec-
tive LD50 levels.65–67 However, recent results from Krigs-
feld et al. have indicated that radiation-induced coagu-
lopathy (RIC) and clinical sequelae that mimic dissemi-
nated intravascular coagulation (DIC) can result in hem-
orrhage, microvascular thrombosis, organ damage, and
death from multiorgan failure from exposure of large an-
imals (including ferrets and pigs) to doses of radiation
at or near the species’ LD50.68–72 RIC-associated hem-
orrhage occurs well before the expected decline in pe-
ripheral platelet counts after irradiation. Rodents do
not exhibit signs of hemorrhage or disorders of primary
hemostasis at time of necropsy after lethal radiation ex-
posure at doses near the LD50 dose, while large animals,
including humans, do exhibit hemorrhage at death fol-
lowing radiation exposure. These findings suggest that
humans may be at risk for coagulopathy-induced compli-
cations after radiation exposure in addition to the classi-
cally anticipated (delayed) concerns of infectious seque-
lae or cell-count decline, effects that may not be modeled
by rodent surrogates.
Further, RBE values for proton irradiation vary be-
tween animal models. In general, RBE values increase
with animal size, with mini-pigs demonstrating higher
RBEs than ferrets, and ferrets, in turn, exhibiting higher
RBEs than mice (Table II).44 Numerous studies have fo-
cused on RBE values for hematopoietic cells in mice at
various time points after the animals have been exposed
to different doses of proton or gamma radiation.45,73 In
these rodent models, RBEs do not differ significantly
from 1 at any of the time points or doses of radiation
evaluated. However, similar studies in ferrets and mini-
pigs have demonstrated alterations of RBE value that are
dependent upon animal model, type of radiation, time
since exposure, and cell-line evaluated (for example, to-
tal white blood cell count vs. neutrophils). In one study,
proton-irradiated ferrets examined 48h after exposure
demonstrated RBEs for white blood cells ranging from
1.2-1.6 and RBEs for neutrophils ranging from 1.9-2.1.74
In Yucatan mini-pigs evaluated 4 days after exposure,
the RBEs for white blood cells was found to be 2.4-4.1
and the RBEs for neutrophils was 2.2-5.0 (see Table II,
Figure 6).56
In other experiments, proton exposure in mini-pigs
again resulted in significantly greater hematopoietic in-
jury and white blood cell count reduction than compa-
rable gamma exposure (Figure ??).55,56 The results of
these studies demonstrate that RBE values of different
radiation types, calculated for the same endpoints, can
vary greatly by animal species and cell line. One con-
TABLE II: The Relative Biological Effectiveness (RBE) for
SPE-like protons compared with standard reference radia-
tions (gamma or electron) in animal models.45,56,73,74 The
RBE of proton exposure varies greatly for total white blood
cells (WBC) and specifically for neutrophils when comparing
animal models. Note that ferret RBE values were determined
48h after exposure; mini-pig values were determined 4d post-
irradiation.
Animal WBC Neutrophil
Mouse 1 1
Ferret 1.16–1.6 1.9–2
Mini-Pig 2.4–4.1 2.2–5
tributing factor may be the repair capacity of the blood
cell renewal systems in mice; such capabilities appear
to be lacking in mini-pigs (an animal model with more
human-like hematopoietic characteristics), making them
more susceptible to radiation-induced declines in cell
counts. Given the presumed closer approximation of ra-
diation effects in larger animals to human-specific con-
sequences, this suggests that space radiation-specific
RBE values for humans may be considerably higher than
those in mice.
These studies demonstrated novel efforts towards an
integrated, physiology-based approach for the evaluation
of organ system- and species-specific endpoints. Us-
ing a more comprehensive evaluation of radiation toxic-
ity for multiple doses and dose-rates in multiple animal
models, this effort advanced the understanding of the
impact of genetic heterogeneity and demonstrated that
animal model, physiology, body mass, and fidelity of a
space radiation analog (in this case, a multi-energy pro-
ton spectrum) all contribute to radiation response. Such
efforts towards the integration of the numerous factors
that contribute to radiation-induced effects will be critical
to translation of research results and prediction of clinical
responses in humans.
Finally, studies of the synergistic effects of radiation
combined with spaceflight environment stressors (e.g.
microgravity, environmental factors, isolation and emo-
tional stress, etc.) show that such factors in combina-
tion impart an increased susceptibility to infection and
delayed wound healing.73,75,76 While spaceflight medi-
cal capabilities have been developed for the manage-
ment of some acute injuries, such as wound care and
infection control, it is unclear whether standard man-
agement techniques will be effective against the syn-
ergistic variables that alter wound healing and associ-
ated risks specific to the space environment. Histori-
cally, there has been limited testing on the efficacy of
management techniques, including pharmaceutical in-
terventions, when radiation exposure is a factor. Simi-
larly, few research protocols examining operational med-
ical care have included the additional variables of the
high-stress and isolated environment,77–79 infections re-
lated to the altered bacterial and chemical exposures
specific to space vehicles,80–83 or factors related to grav-
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FIG. 6: Comparison of lymphocyte and neutrophil counts following proton and x-ray (comparable to gamma radiation) expo-
sures in mice, ferrets, and Yucatan mini-pigs. The relative fraction of lymphocyte (a) and neutrophil (b) counts following a
homogeneous proton or x-ray exposure to the bone marrow compartment are shown. Note: calculations indicate that animals
received approximately a 2Gy marrow dose. In both cases, the mouse models demonstrated the ability to fully recover within
30 days following proton exposures while the ferret and pig models showed no recovery. The ferrets were euthanized at day
13.44 The RBE values for white blood cell counts varied greatly between the mice, ferret and pig models. RBE values were
greater in ferrets than mice, and considerably greater in pigs compared to either ferrets or mice. This suggests that model-
specific sensitivity to radiation exposure may lead to drastically different results in experimental outcome, leading to difficulty
in extracting clinical significance from animal models with dissimilar radiation sensitivity compared to humans. Figure adapted
from Kennedy44 (mouse and ferret results) and Krigsfeld et al.68,69 (Yucatan mini-pig results)
itational unloading,75,84–86 and no studies have effec-
tively examined all of these variables simultaneously. It
is unclear whether these complex interactions can be
fully simulated even in large animal models for appro-
priate extrapolation of human risk. There is a need to
better understand the mechanism of the synergistic ef-
fects observed, define appropriate animal models for
analog research efforts, and determine efficacy of stan-
dard treatments against damage resulting from radiation-
combined injury. Dedicated effort towards these goals
will better allow for operationally relevant and appropri-
ate countermeasures.87
Translation of Space Radiobiology Research to Human Health
Outcomes
Biological damage from radiation exposure is gen-
erally classified as deterministic, dose threshold-based
effects related to significant cell damage or death (for
example, the spectrum of clinical manifestations that
make up Acute Radiation Sickness), or stochastic, where
increased exposure is associated with increased risk
though no threshold dose is necessary for biological im-
pact (for example, carcinogenesis).88 Currently, carcino-
genesis is the only long-term, stochastic effect that has a
clearly defined permissible exposure limit in spaceflight.
Terrestrial radiation (e.g. occupational or clinical radio-
therapy gamma or x-ray exposures) is known to be as-
sociated with carcinogenic risk;89 at this time, there is
no definitive evidence that space radiation causes hu-
man cancer, but it is reasonable to assume that it can.
The dose-equivalent of radiation received by astronauts
currently traveling to the ISS for 6 months is approxi-
mately 100mSv;90 doses of 100mSv of terrestrial radi-
ation sources have been associated with an elevated
cancer risk in human populations.89 NASA’s "Lifetime
Surveillance of Astronaut Health" (LSAH) program doc-
uments cancer cases in astronauts, among other health
parameters. Previous review of LSAH data suggests that
there may be evidence of increased cancer risk in astro-
nauts compared to a control population, though data are
inconclusive and limited by the very small sample size.91
Most evidence for the effects of space-like radiation
exposures in humans has been derived from epidemi-
ological studies on the atomic-bomb survivors, radio-
therapy patients, and occupationally-exposed workers.
These studies have focused on the association between
ionizing radiation exposure and the long-term develop-
ment of degenerative tissue effects such as heart dis-
ease, cataracts, immunological changes, cancer, and
premature aging for moderate to high doses of low-LET
radiation.1,8 The findings are further supported by results
of laboratory studies using rodent animal models.92 How-
ever, true risks for these diseases from low dose-rate ex-
posures to GCR and intermittent SPE are much more
difficult to assess due to long latency periods and the
numerous challenges involved in studying the radiation
environment.92 Additionally, the types of radiation expo-
sure produced by atomic bombs (high dose and high
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FIG. 7: Results from Yucatan mini-pigs exposed to simulated
Solar Particle Event (SPE)-like radiation consisting of sev-
eral different energies of protons. In this study, Kennedy et al.
utilized an inhomogeneous distribution of protons that resem-
bled a SPE spectrum, as demonstrated in Figure 4. Electrons
were used as the surrogate radiation for determining the RBE
following exposure to a SPE-like distribution of protons. Elec-
trons were chosen because a SPE-like distribution could not
be achieved with 60Co as demonstrated in Figure 4(b). Note
the white blood cell counts in the mini-pig model recovered to
near pre-irradiation levels following exposure to the electron
radiation while the white blood cell counts for those exposed
to a SPE-like proton spectrum remained suppressed for 30
days after exposures. These results indicate that the mini-
pigs were not capable of repairing the hematopoietic damage
caused by the proton radiation exposure as efficiently as they
could repair the electron radiation damage. Figure adapted
from Kennedy 2014.44
dose-rate gamma and neutron radiation) are dissimilar
to radiation exposures for astronaut crews during space-
flight.
The theoretical, calculated RBEs for some space
radiation-induced cancers are quite high, which has led
to speculation that the risk of cancer development from
space radiation exposure is at least as high, and perhaps
higher, than the risk of cancer development from expo-
sure to radiation on Earth.93,94 However, there are cur-
rently no biophysical models that can accurately project
all acute, subacute, degenerative, and carcinogenic risks
specific to the range of particles and energies of ion-
izing radiation in the space environment. There is lit-
tle information available about dose response and dose-
rate modifiers for specific effects or about the degener-
ative effects associated with ionizing radiation, and very
few biological models describe degenerative processes
(e.g. cardiovascular degeneration) caused by ionizing
radiation.95
Exposure to the LEO radiation environment has been
associated with alterations to chromatin structure.96–99
However, it is not well understood how such damage
relates to impacts on cellular function or long-term car-
cinogenic risk. There is a paucity of understanding re-
garding the interpretation of chromosomal damage rates
identified in astronauts and the long-term effects induced
by the space radiation environment, without relying on
terrestrial studies of different radiation sources, doses,
dose-rates, or complexity for context. For example,
NASA’s Human Research Program Evidence Report on
the Risk of Radiation Carcinogenesis100, published in
2016, cites numerous studies to provide an assessment
of risk for chromosomal damage (and, ultimately, car-
cinogenesis). A review of the studies cited in this re-
port highlights the limitations described throughout this
manuscript, including reliance upon mono-energetic ra-
diation sources36,38,40,99,101,102, comparison to or inter-
pretation of results in the context of gamma or x-ray
exposures38,40,101–103, or use of dose or dose-rates far
exceeding those expected during spaceflight.36,38,40,99
Indeed, many of these same factors are cited as limita-
tions to NASA’s primary radiation cancer risk prediction
model.104
In addition, few studies have assessed mutation rates
due to LEO radiation at a whole genome level. Whole
genome sampling techniques are being employed for
other carcinogenic stressors.105 Direct observations of
mutation rates, as well as an understanding of the epi-
genetic changes and cellular damage using in vitro cell
culture models, may now be possible due to recent ad-
vances in long-term cell culture aboard the ISS.106 Quan-
tification of observable mutation rates from LEO expo-
sures may better inform future modeling efforts and pro-
vide a critical understanding of the molecular mecha-
nisms behind observed pathologies. However, even data
obtained from the LEO environment is less than ideal, as
the ISS is heavily shielded and the close proximity of the
Earth provides significant protection from radiation expo-
sure. While improved understanding of the LEO environ-
ment may help inform risk predictions, there is significant
work to be done in characterizing these risks in the radi-
ation environment outside of LEO.
Discussion
The health risks associated with exposures to space
radiation will become more onerous as future manned
spaceflight missions require extended transit outside of
LEO and beyond the protection of the Earth’s magne-
tosphere. The indigenous shielding provided by the
Earth’s magnetic field attenuates the major effects of
space radiation exposures for current LEO missions;
in the highly mixed-field environment of interplanetary
space, radiation dose could increase dramatically. Even
behind shielding, secondary particles produced by inter-
actions of primary cosmic rays and the atomic molecules
of the spacecraft structure can deliver a significant frac-
tion of the total dose equivalent. Astronaut crews could
be exposed to multiple SPEs of unpredictable magnitude
with doses that could induce clinical illness and exacer-
bate biological outcomes from the chronic GCR environ-
ment.
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The limited accumulation of knowledge to date has yet
to provide sufficient data for even an estimation of total
risk, let alone predictions of human clinical outcomes or
appropriate mitigation strategies before, during, or after
exposure. Accurately simulating the spectrum of ener-
gies, ion species, doses, and dose-rates found in the
space radiation environment is a non-trivial endeavor.
For the numerous reasons described above, emulation
of the radiation environment, choice of surrogate animal
model, and delivery of appropriate complexity, rate, and
magnitude of dose have all limited the knowledge avail-
able for extrapolation of radiation risk within the context of
spaceflight. These factors have limited our ability to de-
velop operational and useful medical countermeasures
to mitigate the radiation risk of future exploration-class
spaceflight.
To improve upon the limitations described, there must
be a focused effort to develop novel or new methods of
simulating the space radiation environment in more re-
alistic analogs. This should include more realistic dose-
rate studies that can determine if presumed or modeled
outcomes are being observed at mission relevant dose-
rates and dose. Additionally, heavier utilization of the
animal laboratory on board the ISS with comparison of
tissues, organ, and blood samples, identifying realistic
dose thresholds and dose-rates, and comparing these
data to ground-based studies, would greatly improve the
current approach to analog construction. The use of
animal models should be strategic and consistent with
species, strain, dose, and dose-rates with an effort to-
wards the highest-fidelity studies possible for human risk
extrapolation.59 While rodent models may be highly use-
ful for initial characterization studies and for statistically
significant outcomes, true advances are more likely to
come from an effort to utilize larger animals with more
human-like physiology for landmark studies on how spe-
cific outcomes may translate to humans. Finally, while
there would be numerous challenges and ethical consid-
erations involved, studies of non-human primates for fi-
nal validation of risk andmitigation strategies would likely
prove highly beneficial for the protection of future human
crews.
As described above, NASA’s updated GCR simulator
may be able to provide some improvements to simulation
studies by use of rapid-sequential mono-electric beam
exposures.39,41 Recent developments by Chancellor et
al. demonstrate the potential for more accurate analog
recreation of the GCR radiation environment by allow-
ing for continuous generation of ionizing radiation that
more closely matches the ion distribution, LET spec-
trum, and dose-rate of GCR (Figure 8).42 These recent
findings suggest that the radiation environment inside
spaceflight vehicles can be experimentally generated by
perturbing the intrinsic properties of hydrogen-rich crys-
talline materials in order to produce specific nuclear spal-
lation processes when placed in an accelerated mono-
energetic heavy ion beam. Such an approach could al-
low for vast improvements to the simulation of the com-
plex mix of nuclei and energies found in the space radi-
ation spectrum.42
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FIG. 8: Moderator block geometry concept for the emulation
of space radiation spectra. A primary beam of 56Fe (iron,
left) is selectively degraded with a carefully-designed moder-
ator block to produce a desired distribution of energies and
ions (represented by the colorful lines on the right) simulat-
ing the intravehicular space radiation environment. To pref-
erentially enhance fragmentation and energy loss, cuts (white
sections on the left) are performed in the moderator block
made up of different materials (depicted by different shades
of gray). Before the spallation products exit the moderator
block, a high-Z material layer is added for scattering. The
inset shows the circular beam spot, as well as the symmetric
cuts made into the moderator block. Adapted from Chancel-
lor et al. 2017.42
Potential radiation exposure to astronaut crews occurs
on a timescale that is measured in days to months for
SPE and GCR. Technological, practical, and financial
considerations make continuously irradiating animals for
more than a few hours exceedingly difficult. In addition,
because the lifespan of most experimental animals is
more than an order of magnitude shorter than the human
lifespan, the interpretation of long-term, low dose-rate
exposures using such models would be questionable
even given the open opportunity to perform long-duration
experiments. As radiation dose-rate can have a major
impact on modulating the severity of the radiation re-
sponse, it is critical to obtain at least some dose-rate data
for radiation experiments investigating clinical outcomes
of space radiation exposures. While some radiation ef-
fects are either unchanged or mitigated by decreased
dose-rates, data on non-targeted radiation effects (such
as genomic instability and adaptive responses) suggest
that dose response could be altered at lower dose-rates,
with significant differences in quantitative (slope of the
dose-toxicity curve) or qualitative (toxicity effects) biolog-
ical responses. This is especially true for high-LET radi-
ation exposure under conditions of increased oxidative
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stress promoted by spaceflight.107–110 In previous stud-
ies on SPE-like radiation, dose-rates from 17cGy/hour
up to 50cGy/minute have been modeled experimentally
and statistical analysis of these data have begun to ex-
plore the potential quantitative or qualitative impact of
dose-rate on the toxicity of multi-energy spectrum.14 Use
of such data to better design dose-rate extrapolation ex-
periments would be highly useful for more robust, future
studies.
There have been other advances in fields related to
space radiation effects, including whole genome se-
quencing as well as transcriptional, proteomic, and
epigenomic studies of cellular response. There is a
growing list of genes known to affect radiation sensitiv-
ity for many different biological effects of radiation (e.g.
molecular, chromosomal, signal transduction-associated
growth-regulating changes, cell killing, animal tissue and
tumor acute and late effects, and animal carcinogene-
sis). Even so, there is a need to correlate observed
sequence changes with corresponding alterations of
radiosensitivity.88 Incorporation of these investigational
directions opens new opportunities to evaluate space ra-
diation risk on a genomic level, defining risk and allowing
for improved understanding of the pathology of radiation-
induced injury and the potential for intervention in such
processes.
Finally, there are a number of lessons that may be
learned from historical spaceflight and the health of early
space pioneers, though it has been difficult to extract
meaningful conclusions from historical data. For exam-
ple, some sources suggest that there is no statistically
significant increase in carcinogenesis in Apollo, Space
Shuttle, or ISS astronaut crews in comparison to the av-
erage U.S. population; other reviews of data suggest that
risk is indeed increased for astronauts.1,14,91,94 Given
that the broad research base has utilized non-ideal and
highly-limited analogs for the prediction of risk, the fact
that reality has deviated from theoretical, calculated risk
is not entirely surprising. Medicine does not advance
without clarifying treatment options using human sub-
jects. Models and animal data are useful surrogates
for space radiation studies but provide limited benefit for
the interpretation to human outcomes, and studies on
humans exposed to occupational radiation and clinical
radiotherapy are imperfect proxies. The reliance upon
these surrogates continues to limit the ability to translate
radiation knowledge to spaceflight scenarios.
We now have the benefit of a larger, cumulative astro-
naut population that has flown in space while exposed to
a variety of doses that exceed the identified thresholds
for some degenerative and carcinogenic outcomes. The
health of these astronauts, including early indicators of
disease, is closely monitored by NASA medical and epi-
demiological resources with yearly medical examinations
and careful records of clinical outcomes. This provides
critical, real human data that could be used to evaluate
the actual long-term health risk of space radiation. Un-
derstandably, these data are limited to highly sensitive
and protected internal review in order to ensure the pri-
vacy of flown astronauts, given small sample sizes and
the risk of inadvertent identification through mission- or
demographic-specific details. This should not preclude
NASA from taking advantage of these data points while
remaining vigilant with prioritizing the privacy and protec-
tion of astronaut medical health records. The application
of this source of data will enhance our understanding of
the true risk of space radiation, the characterization of
human clinical outcomes, and the development of ap-
propriate mitigation strategies.
Conclusions
The scientific community has struggled to collect
meaningful and robust data for the characterization of the
space radiation environment and the risk that such an en-
vironment poses to future astronaut crews. While many
of the challenges outlined herein have plagued historical
research endeavors, there are significant improvements
that could be made to research design that would im-
prove upon our ability to better predict risk and provide re-
alistic strategies and risk posturing for future exploration
spaceflight. Use of improved modeling techniques to
emulate the space environment, selection of appropriate
biological surrogates for extrapolation of human effects,
and careful use of flown astronaut data could provide
much-needed advances in space radiation research. As
humans seek to explore space outside of the close prox-
imity and protection of LEO, we have the responsibility to
address the space radiation risk to the extent of terres-
trial capabilities in order to provide the best information
and protection possible for our future explorers.
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RID: Radiation-Induced Death
SPE: Solar Particle Event
Sv: Sievert
µm: micrometer
WR: Weighting Factor
Acknowledgments
H.G.K. acknowledges support from the NSF (Grant No. DMR-1151387). Part
of the work of H.G.K.and J.C.C. has been based upon work supported by the
Office of the Director of National Intelligence (ODNI), Intelligence Advanced Re-
search Projects Activity (IARPA), via Interagency Umbrella Agreement IA1-1198.
The views and conclusions contained herein are those of the authors and should
not be interpreted as necessarily representing the official policies or endorse-
ments, either expressed or implied, of the ODNI, IARPA, or the U.S. Govern-
ment. The U.S. Government is authorized to reproduce and distribute reprints
for Governmental purposes notwithstanding any copyright annotation thereon.
Author Contributions
J.C.C. developed the concept of the review. J.C.C., K.A.C., and H.G.K. con-
tributed to the discussion on space physics. J.C.C., R.S.B., S.M.A. and K.A.C.
contributed to the discussion on operational space radiation. J.C.C., K.A.C.
and A.R.K. contributed to the discussion on dosimetry. J.C.C., R.S.B., S.M.A.,
K.H.R., and A.R.K. contributed to the discussion on countermeasures. R.S.B.,
S.M.A., K.A.C., K.H.R., and A.R.K. contributed to the discussion on clinical ef-
fects of space radiation on humans. J.C.C., R.S.B., S.M.A., K.A.C., K.H.R,
and A.R.K. contributed to the discussion on space radiobiology. J.C.C., R.S.B.,
S.M.A., K.A.C., K.H.R, and A.R.K. contributed to the discussion on animal mod-
els. R.S.B., K.H.R., and A.R.K. contributed to the discussion on genetics. J.C.C.,
K.A.C., and H.G.K. contributed to the discussion on computational modeling. All
authors contributed equally to the review of the literature, discussion on the in-
terpretation of research outcomes to spaceflight operations, and drafting of the
manuscript.
Competing financial interests
The authors declare that they have no competing financial interests.
1 Tech. Rep. NCRP 98, National Council on Radiation Pro-
tection and Measurements, Bethesda, MD (1989).
2 Tech. Rep. NCRP Commentary No. 23, National Council
on Radiation Protection and Measurements, Bethesda, MD
(2015).
3 N. Aeronautics and S. Administration, Tech. Rep. NASA-
STD-3001 VOL 1 REV A, Washington, DC (2015).
4 N. A. Schwadron, J. B. Blake, A. W. Case, C. J. Joyce,
J. Kasper, J. Mazur, N. Petro, M. Quinn, J. A. Porter, C. W.
Smith, et al., Does the worsening galactic cosmic radiation
environment observed by CRaTER preclude futuremanned
deep space exploration?, J. SpaceWeather 12, 622 (2014),
ISSN 15427390.
5 F. H. Attix, Introduction to radiological physics and radia-
tion dosimetry (Wiley, New York, 1986), ISBN 978-0-471-
01146-0.
6 E. J. Hall and A. J. Giaccia, Radiobiology for the radiologist
(Wolters Kluwer Health : Lippincott Williams and Wilkins,
Philadelphia, PA, 2012), ISBN 978-1-60831-193-4.
7 J. F. Ziegler, Handbook of stopping cross-sections for en-
ergetic ions in all elements (Elsevier Science : Pergamon
Press, Burlington, 2013), ISBN 978-1-4831-4820-5.
8 Tech. Rep. NCRP Report No. 153, NCRP, Bethesda, MD
(2006).
9 F. A. Cucinotta, M.-H. Y. Kim, and L. Ren, Evaluating shield-
ing effectiveness for reducing space radiation cancer risks,
Radiat. Meas. 41, 1173 (2006), ISSN 13504487.
10 J. A. Simpson, Elemental and Isotopic Composition of the
Galactic Cosmic Rays, Annu. Rev. Nucl. Part. Sci. 33, 323
(1983), ISSN 0163-8998, 1545-4134.
11 G. D. Badhwar, W. Atwell, B. Cash, V. M. Petrov, Y. Akatov,
I. V. Tchernykh, V. A. Shurshakov, and V. A. Arkhangelsky,
Radiation environment on the Mir orbital station during so-
lar minimum, Adv Space Res 22, 501 (1998), ISSN 0273-
1177.
12 F. A. Cucinotta, W. Schimmerling, J. W. Wilson, L. Peter-
son, G. Badhwar, P. Saganti, and J. Dicello, TR JSC-29295,
National Aeronautics and Space Administration, Johnson
Space Center (2001).
13 F. A. Cucinotta and M. Durante, Cancer risk from exposure
to galactic cosmic rays: implications for space exploration
by human beings, J.-Lancet Oncology 7, 431 (2006), ISSN
1470-2045.
14 J. Chancellor, G. Scott, and J. Sutton, Space Radiation:
The Number One Risk to Astronaut Health beyond Low
Earth Orbit, Life 4, 491 (2014), ISSN 2075-1729.
15 S. A.Walker, L. W. Townsend, and J.W. Norbury,Heavy ion
contributions to organ dose equivalent for the 1977 galactic
cosmic ray spectrum, Adv. Space Res. 51, 1792 (2013),
ISSN 02731177.
16 B. B. Rossi, High-Energy Particles (Prentice-Hall, New
York, 1952).
17 P. E. Hodgson, E. Gadioli, and E. Gadioli-Erba, Introductory
Nuclear Physics (Oxford Univ. Press, New York, 1997).
18 S. Guetersloh, C. Zeitlin, L. Heilbronn, J. Miller,
T. Komiyama, A. Fukumura, Y. Iwata, T. Murakami,
and M. Bhattacharya, Polyethylene as a radiation shielding
standard in simulated cosmic-ray environments, Nucl.
Instrum. Methods Phys. Res., Sect. B 252, 319 (2006),
ISSN 0168583X.
19 L. W. Townsend, F. A. Cucinotta, J. W. Wilson, and
R. Bagga, Estimates of HZE particle contributions to SPE
radiation exposures on interplanetary missions, Adv. Space
Res. 14, 671 (1994), ISSN 0273-1177.
20 C. E. Hellweg and C. Baumstark-Khan, Getting ready for
the manned mission to Mars: the astronauts’ risk from
space radiation, Die Naturwissenschaften 94, 517 (2007),
ISSN 0028-1042.
21 J. W. Wilson, F. A. Cucinotta, J. L. Shinn, L. C. Simonsen,
R. R. Dubey, W. R. Jordan, T. D. Jones, C. K. Chang, and
M. Y. Kim, Shielding from solar particle event exposures
in deep space, Radiat. Meas. 30, 361 (1999), ISSN 1350-
4487.
22 D. F. Smart andM. A. Shea,Comment on estimating the so-
lar proton environment that may affect Mars missions, Adv.
Space Res. 31, 45 (2003), ISSN 0273-1177.
23 S. Hu, M.-H. Y. Kim, G. E. McClellan, and F. A. Cucinotta,
Modeling the acute health effects of astronauts from expo-
14
sure to large solar particle events, Health Phys. 96, 465
(2009), ISSN 1538-5159.
24 J. Wilson, Overview of radiation environments and human
exposures, Health Physics 79, 470 (2000).
25 Goddard space flight center, https://cdaweb.sci.gsfc.
nasa.gov/index.html/, accessed: 2017-10-30.
26 M. S. Clowdsley, J. E. Nealy, J. W. Wilson, B. M. Anderson,
M. S. Anderson, and S. A. Krizan, Radiation protection for
lunar mission scenarios (2005).
27 H. Wu, J. L. Huff, R. Casey, M.-H. Kim, and F. A. Cucinotta,
TR NASA/SP-2009-3405, National Aeronautics and Space
Administration, Johnson Space Center (2008).
28 R. Mewaldt, A. Davis, W. Binns, G. de Nolfo, J. George,
M. Israel, R. Leske, E. Stone, M. Wiedenbeck, and T. von
Rosenvinge, in ICRC2005 (Pune, Maharashtra, 2005),
vol. 2, pp. 101–104.
29 K. A. Cengel, E. S. Diffenderfer, S. Avery, A. R. Kennedy,
and J. McDonough, Using electron beam radiation to simu-
late the dose distribution for whole body solar particle event
proton exposure, Radiat. Environ. Biophys. 49, 715 (2010),
ISSN 1432-2099.
30 F. A. Cucinotta, M.-H. Y. Kim, and L. Ren, TR NASA/TP-
2005-213164, National Aeronautics and Space Administra-
tion, Johnson Space Center (2005).
31 A. Edwards, RBE of Radiations in Space and the Implica-
tions for Space Travel, Physica Med. 17, 147 (2001).
32 R. Setlow, Radiation Hazards to Crews of Interplanetary
Missions: Biological Issues and Research Strategies (Na-
tional Academies Press, Washington, D.C., 1996), ISBN
978-0-309-05698-4.
33 P. B. Saganti, F. A. Cucinotta, J. W.Wilson, L. C. Simonsen,
and C. Zeitlin, Radiation climate map for analyzing risks to
astronauts on the mars surface from galactic cosmic rays,
Space Sci. Rev. 110, 143 (2004), ISSN 0038-6308.
34 J. D. Cherry, B. Liu, J. L. Frost, C. A. Lemere, J. P. Williams,
J. A. Olschowka, and M. K. OâĂŹBanion, Galactic Cosmic
Radiation Leads to Cognitive Impairment and Increased aβ
Plaque Accumulation in a Mouse Model of Alzheimer’s Dis-
ease, PLoS One 7, e53275 (2012), ISSN 1932-6203.
35 V. K. Parihar, B. Allen, K. K. Tran, T. G. Macaraeg, E. M.
Chu, S. F. Kwok, N. N. Chmielewski, B. M. Craver, J. E.
Baulch, M. M. Acharya, et al., What happens to your brain
on the way to Mars, Sci. Adv. 1, e1400256 (2015), ISSN
2375-2548.
36 M. Durante, K. George, H. Wu, and F. Cucinotta, Kary-
otypes of human lymphocytes exposed to high-energy iron
ions., Radiation Research 158, 581 (2007).
37 M. Durante, K. George, G. Gialanella, G. Grossi,
C. La Tessa, L. Manti, J. Miller, M. Pugliese, P. Scampoli,
and F. Cucinotta, Cytogenetic effects of high-energy iron
ions: Dependence on shielding thickness and material.,
Radiation Research 164, 571 (2007).
38 H. Wang and Y. Wang, Heavier ions with a different linear
energy transfer spectrum kill more cells due to similar inter-
ference with the ku-dependent dna repair pathway., Radia-
tion Research 182, 458 (2015).
39 J. W. Norbury, W. Schimmerling, T. C. Slaba, E. I. Azzam,
F. F. Badavi, G. Baiocco, E. Benton, V. Bindi, E. A. Blakely,
S. R. Blattnig, et al., Galactic cosmic ray simulation at the
NASA Space Radiation Laboratory, Life Sci. Space Res. 8,
38 (2016), ISSN 22145524.
40 B. Loucas and M. Cornforth, The let dependence of unre-
paired chromosome damage in human cells: a break too
far?, Radiation Research 179, 393 (2015).
41 T. Slaba, S. Blattnig, J. Norbury, A. Rusek, C. La Tessa,
and S. Walker, Tech. Rep. NASA/TP-2015-218698 (2015).
42 J. C. Chancellor, S. Guetersloh, K. Cengel, J. Ford, and
H. Katzgraber, Tech. Rep. 1706.02727 (2017).
43 X. Elmore, R. Kapadia, M. Swete, and J. Redpath,Neoplas-
tic transformation in vitro by mixed beams of high-energy
iron ions and protons, Radiation Research 176, 291 (2011).
44 A. R. Kennedy, Biological effects of space radiation and
development of effective countermeasures, Life Sci. Space
Res. 1, 10 (2014), ISSN 22145524.
45 A. L. Romero-Weaver, X. S. Wan, E. S. Diffenderfer, L. Lin,
and A. R. Kennedy, Effect of SPE-like proton or photon ra-
diation on the kinetics of mouse peripheral blood cells and
radiation biological effectiveness determinations, Astrobiol-
ogy 13, 570 (2013), ISSN 1557-8070.
46 G. Coutrakon, E. Benton, D. Gridley, T. Hickey, J. Hubbard,
P. Koss, M. Moyers, G. Nelson, M. Pecaut, E. Sanders,
et al., Simulation of a 36h solar particle event at LLUMC
using a proton beam scanning system, Nucl. Instrum. Meth-
ods Phys. Res., Sect. B 261, 791 (2007), ISSN 0168583X.
47 M.-H. Y. Kim, K. A. George, and F. A. Cucinotta, Evaluation
of skin cancer risk for lunar and Mars missions, Adv. Space
Res. 37, 1798 (2006), ISSN 02731177.
48 M. Billings, W. Yucker, and B. Heckman, TR MDC-G4131,
McDonald Douglas Astronautics Company West (1973).
49 J. W. Wilson, M. Kim, W. Schimmerling, F. F. Badavi, S. A.
Thibeault, F. A. Cucinotta, J. L. Shinn, and R. Kiefer, Issues
in space radiation protection: galactic cosmic rays, Health
Phys. 68, 50 (1995), ISSN 0017-9078.
50 A. R. Kennedy, J. G. Davis, W. Carlton, and J. H. Ware, Ef-
fects of Dietary Antioxidant Supplementation on the Devel-
opment of Malignant Lymphoma and Other Neoplastic Le-
sions in Mice Exposed to Proton or Iron-Ion Radiation, Ra-
diat. Res. 169, 615 (2008), ISSN 0033-7587, 1938-5404.
51 H. Paganetti, Nuclear interactions in proton therapy: dose
and relative biological effect distributions originating from
primary and secondary particles, Phys. Med. Biol. 47, 747
(2002), ISSN 0031-9155.
52 J. D. Slater, Clinical applications of proton radiation treat-
ment at Loma Linda University: review of a fifteen-year ex-
perience, Technol. Cancer Res. Treat. 5, 81 (2006), ISSN
1533-0346.
53 N. Tilly, J. Johansson, U. Isacsson, J. Medin, E. Blomquist,
E. Grusell, and B. Glimelius, The influence of RBE varia-
tions in a clinical proton treatment plan for a hypopharynx
cancer, Phys. Med. Biol. 50, 2765 (2005), ISSN 0031-9155.
54 C. O.Wambi, J. K. Sanzari, C. M. Sayers, M. Nuth, Z. Zhou,
J. Davis, N. Finnberg, J. S. Lewis-Wambi, J. H. Ware, W. S.
El-Deiry, et al., Protective effects of dietary antioxidants
on proton total-body irradiation-mediated hematopoietic cell
and animal survival, Radiat. Res. 172, 175 (2009), ISSN
0033-7587.
55 J. K. Sanzari, X. S. Wan, A. J. Wroe, S. Rightnar, K. A. Cen-
gel, E. S. Diffenderfer, G. S. Krigsfeld, D. S. Gridley, and
A. R. Kennedy, Acute hematological effects of solar parti-
cle event proton radiation in the porcine model, Radiat. Res.
180, 7 (2013), ISSN 1938-5404.
56 J. K. Sanzari, S. X. Wan, E. S. Diffenderfer, K. A. Cengel,
and A. R. Kennedy, Relative biological effectiveness of sim-
ulated solar particle event proton radiation to induce acute
hematological change in the porcine model, J. Radiat. Res.
(Tokyo) 55, 228 (2014), ISSN 1349-9157.
57 M. P. Little, E. J. Tawn, I. Tzoulaki, R. Wakeford, G. Hilde-
brandt, F. Paris, S. Tapio, and P. Elliott, A systematic review
15
of epidemiological associations between low and moder-
ate doses of ionizing radiation and late cardiovascular ef-
fects, and their possible mechanisms, Radiat. Res. 169, 99
(2008), ISSN 0033-7587.
58 A. Gawrylewski, The Trouble with Animal Models, The Sci-
entist 21, 45 (2007).
59 J. P. Williams, S. L. Brown, G. E. Georges, M. Hauer-
Jensen, R. P. Hill, A. K. Huser, D. G. Kirsch, T. J. Macvittie,
K. A. Mason, M. M. Medhora, et al., Animal models for med-
ical countermeasures to radiation exposure, Radiat. Res.
173, 557 (2010), ISSN 1938-5404.
60 D. G. Hackam and D. A. Redelmeier, Translation of re-
search evidence from animals to humans, JAMA 296, 1731
(2006), ISSN 1538-3598.
61 P. Perel, I. Roberts, E. Sena, P. Wheble, C. Briscoe,
P. Sandercock, M. Macleod, L. E. Mignini, P. Jayaram, and
K. S. Khan, Comparison of treatment effects between ani-
mal experiments and clinical trials: systematic review, BMJ
334, 197 (2007), ISSN 1756-1833.
62 D. G. Hackam, Translating animal research into clinical
benefit, Br. Med. J. 334, 163 (2007), ISSN 0959-8138,
1468-5833.
63 R. Harding, Prodromal effects of radiation: Pathways, mod-
els, and protection by antiemetics, Pharmacol. Ther. 39,
335 (1988), ISSN 01637258.
64 M. Morris and T. Jones, A Comparison of Dose-response
Models for Death from Hematological Depression in Differ-
ent Species, Int. J. Radiat. Biol. 53, 439 (1988), ISSN 0955-
3002, 1362-3095.
65 E. Lorenz and C. C. Congdon, Radioactivity biologic effects
of ionizing radiations, Annu Rev Med 5, 323 (1954).
66 C. P. Miller and C. W. Hammond, The role of infection in ra-
diation injury, Trans. Assoc. Am. Physicians 63, 155 (1950),
ISSN 0066-9458.
67 I. U. Boone, K. T. Woodward, and P. S. Harris, Relation be-
tween bactermia and death in mice following x-ray and ther-
mal column exposures, J. Bacteriol. 71, 188 (1956), ISSN
0021-9193.
68 G. S. Krigsfeld, A. R. Savage, P. C. Billings, L. Lin, and A. R.
Kennedy, Evidence for Radiation-Induced Disseminated In-
travascular Coagulation as a Major Cause of Radiation-
Induced Death in Ferrets, IJROBP 88, 940 (2014), ISSN
03603016.
69 G. Krigsfeld, J. Shah, J. Sanzari, L. Lin, and A. Kennedy,
Evidence of disseminated intravascular coagulation in a
porcine model following radiation exposure, Life Sci. Space
Res. 3, 1 (2014), ISSN 22145524.
70 G. S. Krigsfeld and A. R. Kennedy, Is Disseminated In-
travascular Coagulation the Major Cause of Mortality from
Radiation at Relatively Low Whole Body Doses?, Radiat.
Res. 180, 231 (2013), ISSN 0033-7587, 1938-5404.
71 G. S. Krigsfeld, J. K. Sanzari, and A. R. Kennedy, The
effects of proton radiation on the prothrombin and partial
thromboplastin times of irradiated ferrets, Int. J. Radiat. Biol.
88, 327 (2012), ISSN 0955-3002, 1362-3095.
72 G. S. Krigsfeld, A. R. Savage, J. K. Sanzari, A. J. Wroe,
D. S. Gridley, and A. R. Kennedy,Mechanism of hypocoag-
ulability in proton-irradiated ferrets, Int. J. Radiat. Biol. 89,
823 (2013), ISSN 0955-3002, 1362-3095.
73 C. J. Maks, X. S. Wan, J. H. Ware, A. L. Romero-Weaver,
J. K. Sanzari, J. M. Wilson, S. Rightnar, A. J. Wroe, P. Koss,
D. S. Gridley, et al., Analysis of white blood cell counts in
mice after gamma- or proton-radiation exposure, Radiat.
Res. 176, 170 (2011), ISSN 1938-5404.
74 J. Sanzari, X. Wan, G. Krigsfeld, A. Wroe, D. Gridley, and
A. Kennedy, The effects of gamma and proton radiation ex-
posure on hematopoietic cell counts in the ferret model,
Gravitational Space Research 1, 79 (2013).
75 J. K. Sanzari, J. M. Wilson, E. B. Wagner, and A. R.
Kennedy, The combined effects of reduced weightbearing
and ionizing radiation on splenic lymphocyte population and
function, Int. J. Radiat. Biol. 87, 1033 (2011), ISSN 1362-
3095.
76 J. M. Wilson, G. S. Krigsfeld, J. K. Sanzari, E. B.
Wagner, R. Mick, and A. R. Kennedy, Comparison of
hindlimb unloading and partial weight suspension mod-
els for spaceflight-type condition induced effects on white
blood cells, Adv. Space Res. 49, 237 (2012), ISSN 0273-
1177.
77 D. S. Levine and J. E. Greenleaf, Immunosuppression dur-
ing spaceflight deconditioning, Aviat Space Environ Med.
69, 172 (1998), ISSN 0095-6562.
78 B. Crucian, R. J. Simpson, S. Mehta, R. Stowe, A. Chouker,
S.-A. Hwang, J. K. Actor, A. P. Salam, D. Pierson, and
C. Sams, Terrestrial stress analogs for spaceflight associ-
ated immune system dysregulation, Brain Behav. Immun.
39, 23 (2014), ISSN 1090-2139.
79 J. I. Pagel and A. ChoukÃĺr, Effects of isolation and con-
finement on humans-implications for manned space ex-
plorations, J Appl. Physiol. 120, 1449 (2016), ISSN 1522-
1601.
80 T. A. Alekhova, L. M. Zakharchuk, N. Y. Tatarinova, V. V.
Kadnikov, A. V. Mardanov, N. V. Ravin, and K. G. Skryabin,
Diversity of bacteria of the genus Bacillus on board of inter-
national space station, Dokl. Biochem. Biophys. 465, 347
(2015), ISSN 1608-3091.
81 D. L. Pierson,Microbial contamination of spacecraft, Gravit
space biol bull 14, 1 (2001), ISSN 1089-988X.
82 G. Norbiato, T. Vago, and L. Battocchio, Microbial and fun-
gal contamination contributes to physical stress in space
flight: studies in the Euromir-95 mission, Journal of Gravi-
tational Physiology 5, P145 (1998), ISSN 1077-9248.
83 L. A. Mermel, Infection prevention and control during pro-
longed human space travel, Clin. Infect. Dis. 56, 123
(2013), ISSN 1537-6591.
84 M. Li, V. Holmes, H. Ni, J. K. Sanzari, A. L. Romero-
Weaver, L. Lin, A. Carabe-Fernandez, E. S. Diffenderfer,
A. R. Kennedy, and D. Weissman, Broad-spectrum antibi-
otic or G-CSF as potential countermeasures for impaired
control of bacterial infection associated with an SPE expo-
sure during spaceflight, PLoS One 10, e0120126 (2015),
ISSN 1932-6203.
85 M. Li, V. Holmes, Y. Zhou, H. Ni, J. K. Sanzari, A. R.
Kennedy, and D. Weissman, Hindlimb suspension and
SPE-like radiation impairs clearance of bacterial infections,
PLoS One 9, e85665 (2014), ISSN 1932-6203.
86 Y. Zhou, H. Ni, M. Li, J. K. Sanzari, E. S. Diffenderfer, L. Lin,
A. R. Kennedy, and D. Weissman, Effect of solar particle
event radiation and hindlimb suspension on gastrointestinal
tract bacterial translocation and immune activation, PLoS
One 7, e44329 (2012), ISSN 1932-6203.
87 A. L. DiCarlo, R. J. Hatchett, J. M. Kaminski, G. D. Led-
ney, T. C. Pellmar, P. Okunieff, and N. Ramakrishnan,Med-
ical countermeasures for radiation combined injury: radia-
tion with burn, blast, trauma and/or sepsis. report of an NI-
AID Workshop, March 26-27, 2007, Radiat. Res. 169, 712
(2008), ISSN 0033-7587.
88 National Council on Radiation Protection and Measure-
16
ments (NCRP), Tech. Rep. No. 167, National Council on
Radiation Protection and Measurements, Bethesda, Mary-
land (2011).
89 V. Beir, Health Risks from Exposure to Low Levels of Ion-
izing Radiation: BEIR VII Phase 2 (National Academies
Press, Washington, D.C., 2006), ISBN 978-0-309-09156-
5, dOI: 10.17226/11340.
90 M. R. Shavers, N. Zapp, R. E. Barber, J. W. Wilson,
G. Qualls, L. Toupes, S. Ramsey, V. Vinci, G. Smith, and
F. A. Cucinotta, Implementation of ALARA radiation protec-
tion on the ISS through polyethylene shielding augmenta-
tion of the Service Module Crew Quarters, Adv. Space Res.
34, 1333 (2004), ISSN 0273-1177.
91 Longnecker, David E. andManning, Frederick J. andWorth,
Melvin H., ed., Review of NASA’s Longitudinal Study of
Astronaut Health (National Academies Press, U.S. Insti-
tute of Medicine, Washington, D.C, 2004), ISBN 978-0-309-
09148-0 978-0-309-53016-3, oCLC: ocm55201397.
92 E. A. Blakely and P. Y. Chang, A review of ground-based
heavy-ion radiobiology relevant to space radiation risk as-
sessment. Part II: Cardiovascular and immunological ef-
fects, Adv. Space Res. 40, 461 (2007), ISSN 02731177.
93 A. Kennedy and X. Wan, Countermeasures for space radi-
ation induced adverse biological effects, Adv. Space Res.
48, 1460 (2011).
94 F. A. Cucinotta and E. Cacao, Non-targeted effects models
predict significantly higher mars mission cancer risk than
targeted effects models, Scientific Reports 7 (2017).
95 J. Huff and F. Cucinotta, TR NASA/SP-2009-3405, National
Aeronautics and Space Administration, Johnson Space
Center (2009).
96 M. Bender, P. Gooch, and S. Kondo, The gemini-3 s-4
spaceflight-radiation interaction experiment, Radiation Re-
search 31, 91 (1967).
97 B. Fedorenko, S. Druzhinin, L. Yudaeva, V. Petrov, Y. Aka-
tov, G. Snigiryova, N. Novitskaya, V. Shevchenko, and
Rubanovich, Cytogenetic studies of blood lymphocytes
from cosmonauts after long-term space flights on mir sta-
tion, Advanced Space Research 27, 355 (2001).
98 L. Testard, M. Ricoul, F. Hoffschir, A. Flury-Herard, B. Dutril-
laux, B. Federenko, V. Gerasimenko, and L. Sabatier,
Radiation-induced chromosome damage in astronautsâĂŹ
lymphocytes., International Journal of Radiation Biology 70,
403 (1967).
99 K. George and F. Cucinotta, Tech. Rep. JSC-CN-23294,
NASA Johnson Space Center, Houston, TX (2011).
100 J. Huff, L. Carnell, S. Blattnig, L. Chappell, K. George,
S. Lumpkins, L. Simonsen, T. Slaba, and C. Werneth, Tech.
Rep. JSC-CN-35748, Houston, TX (2016).
101 M. Belli, R. Cherubini, and M. Dalla Vecchia, Dna fragmen-
tation in v79 cells irradiated with light ions as measured by
pulsed-field gel electrophoresis: I. experimental results., In-
ternational Journal of Radiation Biology 78, 475 (2002).
102 M. Hada, F. Cucinotta, S. Gonda, and H. Wu, mband anal-
ysis of chromosomal aberrations in human epithelial cells
exposed to low- and high-let radiation., Radiation Research
168, 98 (2007).
103 C. Johannes, M. Horstmann, and D. M, Chromosome intra-
changes and interchanges detected by multicolor banding
in lymphocytes: searching for clastogen signatures in the
human genome, Radiation Research 161, 540 (2007).
104 F. Cucinotta, M. Kim, and L. Chappell, Tech. Rep.
NASA/TP-2013-217375, NASA Johnson Space Center,
Houston, TX (2012).
105 L. B. Alexandrov, Y. S. Ju, K. Haase, P. Van Loo, I. Martin-
corena, S. Nik-Zainal, Y. Totoki, A. Fujimoto, H. Nakagawa,
T. Shibata, et al., Mutational signatures associated with to-
bacco smoking in human cancer, Science 354, 618 (2016),
ISSN 1095-9203.
106 A. Sharma and J. Wu, Personal Communication (2016).
107 E. I. Azzam, J.-P. Jay-Gerin, and D. Pain, Ionizing radiation-
induced metabolic oxidative stress and prolonged cell in-
jury, Cancer Lett. 327, 48 (2012), ISSN 1872-7980.
108 A. M. Rizzo, P. A. Corsetto, G. Montorfano, S. Milani,
S. Zava, S. Tavella, R. Cancedda, and B. Berra, Effects of
long-term space flight on erythrocytes and oxidative stress
of rodents, PLoS One 7, e32361 (2012), ISSN 1932-6203.
109 M. Buonanno, S. M. de Toledo, D. Pain, and E. I. Azzam,
Long-Term Consequences of Radiation-Induced Bystander
Effects Depend on Radiation Quality and Dose and Corre-
late with Oxidative Stress, Radiat. Res. 175, 405 (2011),
ISSN 0033-7587, 1938-5404.
110 H. Matsumoto, M. Tomita, K. Otsuka, and M. Hatashita, A
new paradigm in radioadaptive response developing from
microbeam research, J. Radiat. Res. (Tokyo) 50 Suppl A,
A67 (2009), ISSN 0449-3060.
